review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0009-9120(90)90601-P |
P698 | PubMed publication ID | 2197030 |
P2093 | author name string | Mayer M | |
P2860 | cites work | The induction of differentiation in teratocarcinoma stem cells by retinoic acid | Q33851753 |
P433 | issue | 3 | |
P921 | main subject | plasminogen | Q107129060 |
P304 | page(s) | 197-211 | |
P577 | publication date | 1990-06-01 | |
P1433 | published in | Clinical Biochemistry | Q5133749 |
P1476 | title | Biochemical and biological aspects of the plasminogen activation system | |
P478 | volume | 23 |
Q41684578 | A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor |
Q35436841 | Binding of human plasminogen to Borrelia burgdorferi |
Q44426670 | Cathepsin B in osteoblasts |
Q41033389 | Cell cycle-dependent fluctuation of urokinase-type plasminogen activator, its receptor, and inhibitors in cultured bovine mammary epithelial and myoepithelial cells. |
Q71372215 | Cell surface-bound urokinase-type plasminogen activator facilitates infiltration of freshly isolated granulocytes into fibrin matrix |
Q44297507 | Cellular density regulation of plasminogen gene expression in mouse hepatocytes |
Q42810043 | Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion |
Q51156357 | Coagulation tests show significant differences in patients with breast cancer. |
Q67841718 | Domain structure and interactions of recombinant urokinase-type plasminogen activator |
Q44068270 | Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes. |
Q73025879 | Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta |
Q42455275 | Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid |
Q73029208 | Epidermal growth factor in gingival crevicular fluid and its binding capacity in inflamed and non-inflamed human gingiva |
Q91598075 | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker |
Q34192459 | Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials |
Q43825266 | Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle |
Q41207435 | Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines |
Q35364689 | Fibrinolytic mechanisms in tumor growth and spreading |
Q74330951 | Histamine and tissue fibrinolytic activity in duodenal ulcer disease |
Q42483528 | Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis |
Q73156216 | Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells |
Q73595133 | Indirect enantiomeric separation of 2-arylpropionic acids and structurally related compounds by reversed phase HPLC |
Q43812341 | Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats |
Q79077062 | Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas |
Q72378611 | LPS induces major changes in the extracellular proteolytic balance in the murine kidney |
Q71942000 | Location of the Major ∊-(γ-Glutamyl)lysyl Cross-linking Site in Transglutaminase-modified Human Plasminogen |
Q43632920 | Lysine-derivatized polyurethane as a clot lysing surface: conversion of adsorbed plasminogen to plasmin and clot lysis in vitro |
Q48231496 | Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection |
Q46332546 | Plasmin degradation of fibrin coatings on synthetic polymer substrates |
Q42753873 | Plasminogen activation in healing human wounds |
Q72076062 | Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann |
Q44216178 | Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture |
Q41860282 | Plasminogen in proliferative vitreoretinal disorders |
Q36431096 | Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer |
Q40848847 | Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy? |
Q42179199 | Regulation of fibrinolysis by non-esterified fatty acids |
Q28583849 | Role of plasminogen activators during healing after uterine serosal lesioning in the rat |
Q42111711 | Stimulation of plasmin activity by oleic acid |
Q36893444 | The hemostasis system in murine atherosclerosis |
Q35993610 | The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor |
Q36290177 | The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. |
Q33669873 | The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy |
Q48354828 | Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway |
Q42623917 | Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory |
Q44148364 | Tissue plasminogen activator is required for corticostriatal long-term potentiation. |
Q35731104 | Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein |
Q33842888 | Ventral striatal plasticity and spatial memory |
Q47131104 | Zinc chelation promotes streptokinase-induced thrombolysis in vitro |
Q71899004 | alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds |
Search more.